EyeCool Therapeutics has announced encouraging results from a double-masked, randomized controlled p...
read more
Perfuse Therapeutics has announced promising 24-week results from its Phase 1/2a clinical trial eval...
read more
LumiThera has announced promising results from its LIGHTSITE 3B extension trial, highlighting contin...
read more
Topcon Healthcare has officially launched the Institute of Digital Health (IDHea), a next-generation...
read more
Alkeus Pharmaceuticals, Inc. presented additional 24-month results from its Phase 2 SAGA clinical tr...
read more
Aldeyra Therapeutics has announced that its investigational dry eye disease (DED) candidate, reproxa...
read more
Innovent Biologics has announced the latest 1-year results from its Phase 2 clinical trial evaluatin...
read more
Carl Zeiss Meditec AG has announced a forthcoming change in executive leadership. Dr. Markus Weber, ...
read more
Opus Genetics has presented 12-month results from adult patients enrolled in the ongoing Phase 1/2 c...
read more
UNITY Biotechnology has announced the complete 36-week results from its Phase 2b ASPIRE clinical tri...
read more
More
